Recorded Presentation from the NCCN Pharmacy Updates: New Therapies for Chronic Lymphocytic Leukemia and a Changing Treatment Paradigm
Join Emily K. Dotson, PharmD, BCOP, from The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute for this webinar in the 2018 NCCN Pharmacy Update Series on the topic New Therapies for Chronic Lymphocytic Leukemia and a Changing Treatment Paradigm.
Updates in the Management of CLL: Histologic Transformation and Relapsed/Refractory Disease

Histologic transformation of chronic lymphocytic leukemia (CLL) to more aggressive lymphoma is associated with a poor prognosis since it is typically resistant to standard chemoimmunotherapy regimens used for the treatment of CLL.

NCCN Pharmacy Updates: New Therapies for Chronic Lymphocytic Leukemia and a Changing Treatment Paradigm

Join Emily K.

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Chronic Lymphocytic Leukemia (CLL)

Join Jennifer Brown, MD, PhD, and Matthew Davids, MD, MMSc, from Dana-Farber Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to chronic lymphocytic leukemia (CLL).

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Chronic Lymphocytic Leukemia (CLL)

Join Jennifer Brown, MD, PhD, and Matthew Davids, MD, MMSc, from Dana-Farber Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to chronic lymphocytic leukemia (CLL).

How to Sequence Therapy in Chronic Lymphocytic Leukemia

This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.

Recorded Presentation from the NCCN 2017 Nursing Program Webinar Series - Clinical Updates and Issues: Chronic Lymphocytic Lymphoma

The 2017 NCCN Nursing Program: Advancing Oncology Nursing Live Webinar Series will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.

NCCN 2017 Nursing Program Webinar Series - Clinical Updates and Issues: Chronic Lymphocytic Lymphoma

The 2017 NCCN Nursing Program: Advancing Oncology Nursing Live Webinar Series will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.

Chronic Lymphocytic Leukemia: Individualizing Treatment Approach

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

NCCN Guidelines® Insights - Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017

Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are different manifestations of the same disease and managed in much the same way. The advent of novel CD20 monoclonal antibodies led to the development of effective chemoimmunotherapy regimens.

Pages

Subscribe to RSS - Chronic Lymphocytic Leukemia